 |
市場調查報告書
商品編碼
1110098
克羅恩病治療市場：按藥物類型、按分銷渠道、按地區 - 規模、份額、前景、機會分析，2022-2030Crohn's Disease Treatment Market, by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
價格
簡介目錄
克羅恩病是一種導致消化道炎症的慢性炎症性腸病 (IBD)。這種炎症可以發生在小腸迴腸和大腸結腸之間的任何地方。克羅恩病的常見症狀從輕微到嚴重不等，包括腹痛、食慾不振、發燒和頻繁腹瀉。肛管發炎的裂縫也會導致直腸出血。導致克羅恩病的因素包括遺傳基因、導致炎症的自身免疫反應以及細菌和病毒等環境因素。這種疾病主要影響 15 至 35 歲的人群，並且影響男性和女性。
雖然這種疾病沒有靈丹妙藥，但各種治療方法可以減輕疾病的症狀和體徵，帶來長期的緩解。抗炎藥、免疫抑製劑、抗生素和其他抑制炎症的藥物被用於治療克羅恩病，並有望改善長期預後。
市場動態
北美和歐洲的克羅恩病等炎症性腸病 (IBD) 發病率很高，預計這將推動市場增長。例如，根據 2020 年 12 月發表在《消化醫學研究》上的一篇論文，預計到 2030 年，IBD 的患病率將在北美達到約 400 萬人。根據同一來源，加拿大數據估計，2018 年 IBD 的患病率為每 10 萬人 725 人，到 2030 年上升至每 10 萬人 981 人。因此，預計 IBD 患病率的增加將在預測期內推動市場增長。
本研究的主要特點
- 本報告對全球克羅恩病治療市場進行了深入分析，揭示了以 2021 年為基準年的預測期內（2022-2030 年）的市場規模（十億美元）和復合年增長率 (CAGR%)
- 解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
- 該研究還提供了有關市場驅動因素、抑制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
- 根據公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數，對全球克羅恩病治療市場的主要參與者進行簡介。
- 本研究涉及的主要公司包括 AbbVie Inc.、Janssen Biotech, Inc.、Bristol-Myers Squibb Company、Boehringer Ingelheim GmbH、Pfizer Inc.、Eli Lilly and Company、Novartis AG、Sanofi、Takeda Pharmaceutical Company Limited 、Mylan N.V.、安進公司和阿斯利康
- 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
- 全球克羅恩病治療市場報告面向該行業的各種利益相關者，包括投資者和供應商、產品製造商、分銷商、新進入者和財務分析師。
- 利益相關者可以通過在分析全球克羅恩病治療市場時使用的各種策略矩陣來促進決策制定。
內容
第 1 章目的和先決條件
- 調查目的
- 先決條件
- 縮寫說明
第二章市場展望
- 舉報內容
- 市場定義和範圍
- 執行摘要
- 按藥物類型劃分的市場概況
- 市場快照：按分銷渠道
- 市場概況：按地區劃分
- 連貫的機會圖 (COM)
第 3 章市場動態、法規和趨勢分析
- 市場動態
- 驅動程序
- 約束因素
- 市場機會
- 影響分析
- 主要亮點
- 市場趨勢
- PORTER 的五力分析
- 流行病學
- 新品發布
- 產品類型創新
第 4 章克羅恩病藥物全球市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 對供需的影響
- COVID-19 對市場的影響
第 5 章克羅恩病藥物全球市場：按藥物類型，2017-2030 年
- 抗生素
- 氨基水楊酸鹽
- 皮質類固醇
- 免疫調節劑
- 其他
第 6 章按分銷渠道分列的克羅恩病藥物全球市場：2017-2030
- 醫院藥房
- 零售藥房
- 電子商務
第 7 章。按地區分列的克羅恩病藥物全球市場，2017-2030 年
- 北美
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地區
- 歐洲
- 英國
- 德國
- 意大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 東盟
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東
- 海合會
- 以色列
- 其他中東
- 非洲
- 北非
- 中非
- 南非
第 8 章競爭格局
- AbbVie Inc.
- Janssen Biotech, Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- Amgen Inc.
- AstraZeneca
第九章章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI1237
Crohn's disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small intestine to the colon of the large intestine. Common symptoms of Crohn's disease from mild to severe intensity include abdominal pain, reduced appetite, fever, and frequent diarrhea. Rectal bleeding is encountered in few cases due to fissures from inflammation at anal canal. Factors responsible for causing Crohn's disease include hereditary genes, autoimmune reaction that causes inflammatory condition, and environmental factors such as bacteria and virus. The disease majorly affects people falling between age group of 15-35 years and occurs in both males and females.
There exists no specific cure for the disease, however various therapies can be employed on patients that can help to reduce signs and symptoms of the disease as well as can bring long-term remission. Improvement in long-term prognosis can be achieved through several medications prescribed for the treatment of Crohn's disease that include anti-inflammatory drugs, immune system suppressers, antibiotics and other medication that helps to control inflammation.
Market Dynamics
The North America and Europe regions have high incidence of inflammatory bowel disease (IBD) such as Crohn's disease, which is expected to drive growth of market. For instance, according to an article published in the journal Digestive Medicine Research in December 2020, in North America, the prevalence of IBD is projected to affect approximately 4 million persons by 2030. According to the same source, data from Canada reported a prevalence of IBD at 725 per 100,000 in 2018, which is estimated to rise to 981 by 2030. Thus the increasing prevalence of IBD is expected to drive market growth over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global crohn's disease treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global crohn's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi, Takeda Pharmaceutical Company Limited, Mylan N.V., Amgen Inc., and AstraZeneca
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global crohn's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crohn's disease treatment market
Detailed Segmentation:
- Global Crohn's Disease Treatment Market, By Drug Type:
- Antibiotics
- Amino Salicylates
- Corticosteroids
- Immunomodulators
- Others
- Global Crohn's Disease Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- e-Commerce
- Global Crohn's Disease Treatment Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- AbbVie Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Janssen Biotech, Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- Amgen Inc.
- AstraZeneca
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Market Trends
- PORTER's Five Forces Analysis
- Epidemiology
- New Product Launch
- Product Type Innovation
4. Global Crohn's Disease Treatment Market - Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Crohn's Disease Treatment Market, By Drug Type, 2017 - 2030, (US$ Billion)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Amino Salicylates
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Immunomodulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
6. Global Crohn's Disease Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
- e-Commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
7. Global Crohn's Disease Treatment Market, By Region, 2017 - 2030, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Janssen Biotech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
